Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001415889-25-020786

Options or other derivatives

  • Chief Medical Officer acquired 242,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lechleider Robert Chief Medical Officer 2025-07-29 Grant or award · Employee Stock Option (right to buy) +242,000 242,000 D
Loading xslF345X05/form4-07312025_100718.xml…